Nafamostat Mesylate
-
Catalog number1760-50
-
PricePlease ask
-
Size50 mg
-
-
Alternative_name4-[(Aminoiminomethyl)amino]benzoic acid 6-(aminoiminomethyl)-2-naphthalenyl ester dimethanesulfonate; FUT-175; Futhan
-
DescriptionA broad-spectrum, synthetic serine protease inhibitor and an inhibitor of the classical and alternative ways of complement activation. Displays selectivity for human tryptase when used at relatively low concentrations. Reduces eosinophil infiltration, mast cell activation and airway responsiveness in a murine model of asthma.
-
CAS Number82956-11-4
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₁₉H₁₇N₅O₂.2CH₄O₃S
-
Molecular Weight539.59
-
Cell PermeableYes
-
Purity≥97% by HPLC
-
SolubilitiesDMSO (100 mM) and H₂O (100 mM)
-
HandlingProtect from air and moisture
-
Tag LineA broad spectrum serine protease inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life24 months
-
MDL NumberMFCD00941430
-
PubChem CID5311180
-
SMILESCS(=O)(=O)O.CS(=O)(=O)O.C1=CC(=CC=C1C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(=N)N)N=C(N)N
-
InChiInChI=1S/C19H17N5O2.2CH4O3S/c20-17(21)14-2-1-13-10-16(8-5-12(13)9-14)26-18(25)11-3-6-15(7-4-11)24-19(22)23;2*1-5(2,3)4/h1-10H,(H3,20,21)(H4,22,23,24);2*1H3,(H,2,3,4)
-
InChi KeySRXKIZXIRHMPFW-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameNafamostat Mesylate
-
Alternative nameNafamostat Mesylate
-